fda glp-1 warning letters news AI generated weight loss ads are flooding social media, using fake images and fabricated claims to sell non-FDA approved drugs. These ads are misleading consumers and hide the real risks. We are FDA Sends 30 Warning Letters

They're injectable medications that come in pre-filled pens you administer as subcutaneous injections, in the fatty layer just under your skin

Back Lloyd, E (3 April 2024) 'Global GLP-1 agonist market trends', Pharmacy Learning Network

Both approaches also affect appetite-regulating hormones beyond GLP-1 itself

This is as clear an example as can be seen of regulatory overreach and pharmacological pusillanimity in the misdirected pursuit of safety

Applying the patch for longer periods can lead to side effects such as: Erythema (redness) Pruritus (itching) Contact dermatitis Skin inflammation Burning sensation GLP-1 transdermal patches may also cause hypersensitivity reactions and skin sensitization after repeated exposure

Other drugs that are unapproved or mislabeled have been marketed and sold